BioPharmX Revenue and Competitors
Estimated Revenue & Valuation
- BioPharmX's estimated annual revenue is currently $1.1M per year.
- BioPharmX's estimated revenue per employee is $155,000
Employee Data
- BioPharmX has 7 Employees.
- BioPharmX grew their employee count by 0% last year.
BioPharmX's People
| Name | Title | Email/Phone |
|---|
BioPharmX Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is BioPharmX?
BioPharmX Corporation (NYSE American: BPMX) is a specialty pharmaceutical company focused on developing products that treat chronic dermatologic conditions that are not being adequately addressed or those where current therapies and approaches are suboptimal. The Company is developing prescription products through its proprietary HyantXâ„¢ delivery system for dermatology indications. BioPharmX has two lead products in development, BPX-04 for the treatment of papulopustular rosacea and BPX-01 for the treatment of acne vulgaris.
keywords:N/A
N/A
Total Funding
7
Number of Employees
$1.1M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in San Jose
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.5M | 7 | -22% | $3M |
#2 | $0.7M | 7 | -50% | N/A |
#3 | $0.5M | 7 | N/A | N/A |
#4 | $0.8M | 7 | -12% | N/A |
#5 | $1.8M | 7 | -30% | N/A |